We are live on
!
Find out more
PCM
Price Capital Management Portfolio holdings
AUM
$607K
1-Year Est. Return
46.82%
This Fund
S&P 500
This Quarter
Est. Return
+30.95%
1 Year Est. Return
+46.82%
3 Year Est. Return
+124.29%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$113M
AUM Growth
–
Cap. Flow
+$102M
Cap. Flow
% of AUM
89.55%
Top 10 Holdings %
Top 10 Hldgs %
32.61%
Holding
64
New
64
Increased
–
Reduced
–
Closed
–
Avg Time Held
0
quarters
Top 10 Avg Time Held
0
quarters
Top 20 Avg Time Held
0
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$12M |
| 2 |
Vanguard Total International Bond ETF
BNDX
|
+$7.36M |
| 3 |
Marriott Vacations Worldwide
VAC
|
+$1.89M |
| 4 |
LOCK
LifeLock, Inc.
LOCK
|
+$1.88M |
| 5 |
DFT
DuPont Fabros Technology Inc.
DFT
|
+$1.83M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.92% |
| 2 | Miscellaneous | 24.32% |
| 3 | Technology | 15.16% |
| 4 | Consumer Discretionary | 12.55% |
| 5 | Industrials | 11.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
NXTM
26
DELISTED
NxStage Medical Inc.
NXTM
| $1.55M | 1.37% |
+86,705
| New | +$1.4M |
2014 Q4
0 quarters
|
|
27
Boise Cascade
BCC
$2.62B
| $1.55M | 1.37% |
+41,760
| New | +$1.44M |
2014 Q4
0 quarters
|
|
|
NUVA
28
DELISTED
NuVasive, Inc.
NUVA
| $1.55M | 1.37% |
+32,879
| New | +$1.37M |
2014 Q4
0 quarters
|
|
|
SONC
29
DELISTED
Sonic Corp
SONC
| $1.54M | 1.36% |
+56,648
| New | +$1.44M |
2014 Q4
0 quarters
|
|
30
BJ's Restaurants
BJRI
$1.32B
| $1.54M | 1.36% |
+30,678
| New | +$1.35M |
2014 Q4
0 quarters
|
|
|
SNBR
31
DELISTED
Sleep Number
SNBR
| $1.53M | 1.35% |
+56,561
| New | +$1.41M |
2014 Q4
0 quarters
|
|
32
Acadia Healthcare
ACHC
$2.61B
| $1.51M | 1.33% |
+24,722
| New | +$1.44M |
2014 Q4
0 quarters
|
|
33
Tyler Technologies
TYL
$13.2B
| $1.51M | 1.33% |
+13,761
| New | +$1.45M |
2014 Q4
0 quarters
|
|
34
West Pharmaceutical
WST
$25.7B
| $1.5M | 1.32% |
+28,163
| New | +$1.41M |
2014 Q4
0 quarters
|
|
35
Steris
STE
$20.3B
| $1.47M | 1.3% |
+22,728
| New | +$1.4M |
2014 Q4
0 quarters
|
|
|
ELLI
36
DELISTED
Ellie Mae Inc
ELLI
| $1.47M | 1.3% |
+36,497
| New | +$1.41M |
2014 Q4
0 quarters
|
|
37
EPAM Systems
EPAM
$5.59B
| $1.45M | 1.28% |
+30,297
| New | +$1.43M |
2014 Q4
0 quarters
|
|
38
Ionis Pharmaceuticals
IONS
$7.24B
| $1.35M | 1.19% |
+21,841
| New | +$1.08M |
2014 Q4
0 quarters
|
|
|
MACK
39
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $1.33M | 1.18% |
+15,004
| New | +$1.09M |
2014 Q4
0 quarters
|
|
40
PTC Therapeutics
PTCT
$5.3B
| $1.31M | 1.15% |
+25,218
| New | +$1.11M |
2014 Q4
0 quarters
|
|
|
AMAG
41
DELISTED
AMAG Pharmaceuticals
AMAG
| $1.3M | 1.15% |
+30,570
| New | +$1.1M |
2014 Q4
0 quarters
|
|
42
Neurocrine Biosciences
NBIX
$14.6B
| $1.29M | 1.14% |
+57,840
| New | +$1.1M |
2014 Q4
0 quarters
|
|
43
Agios Pharmaceuticals
AGIO
$1.9B
| $1.29M | 1.13% |
+11,475
| New | +$1.02M |
2014 Q4
0 quarters
|
|
44
Novavax
NVAX
$1.73B
| $1.27M | 1.12% |
+10,694
| New | +$1.12M |
2014 Q4
0 quarters
|
|
|
LUMO
45
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $1.27M | 1.12% |
+3,543
| New | +$1.05M |
2014 Q4
0 quarters
|
|
46
Enanta Pharmaceuticals
ENTA
$377M
| $1.26M | 1.11% |
+24,807
| New | +$1.11M |
2014 Q4
0 quarters
|
|
|
EXAS
47
DELISTED
Exact Sciences
EXAS
| $1.24M | 1.09% |
+45,180
| New | +$1.1M |
2014 Q4
0 quarters
|
|
|
INFN
48
DELISTED
Infinera Corporation Common Stock
INFN
| $1.22M | 1.08% |
+83,148
| New | +$1.1M |
2014 Q4
0 quarters
|
|
|
FRGI
49
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $1.22M | 1.08% |
+20,064
| New | +$1.11M |
2014 Q4
0 quarters
|
|
|
SPNC
50
DELISTED
Spectranetics Corp
SPNC
| $1.22M | 1.07% |
+35,156
| New | +$1.1M |
2014 Q4
0 quarters
|
|
Similar funds
AMC
PA
FWA
PPI
FP
CAGAS
KCP
VS
Price Capital Management's Q4 2014 Portfolio in Review
Q4 2014 is the first quarter with a 13F filing on record for Price Capital Management, which disclosed 64 positions worth $113M. Its ten largest holdings account for 33% of the portfolio.
Its largest position is State Street Consumer Staples Select Sector SPDR ETF: 254,560 shares worth $12.3M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, followed by Miscellaneous and Technology.
- Price Capital Management's largest Q4 2014 buy was State Street Consumer Staples Select Sector SPDR ETF: 254,560 shares worth $12.3M.
- Price Capital Management's ten largest holdings make up 33% of its $113M portfolio in Q4 2014.
- Price Capital Management disclosed 64 positions in Q4 2014, its first 13F filing on record.
Based on Price Capital Management's 13F filing for Q4 2014, filed 12 Feb 2015.